The impact of early CD4+ lymphocyte recovery on the outcome of patients who undergo allogeneic bone marrow or peripheral blood stem cell transplantation

Blood Transfusion

Volumn 10, Issue 2, 2012, Pages 174-180

  Fedele, Roberta ^a   Martino, Massimo ^a   Garreffa, Cristina ^a   Messina, Giuseppe ^a   Console, Giuseppe ^a   Princi, Domenica ^a   Dattola, Antonella ^a   Moscato, Tiziana ^a   Massara, Elisabetta ^a   Spiniello, Elisa ^a   Irrera, Giuseppe ^a   Iacopino, Pasquale ^a  

^a BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

Allogeneic stem cell transplantation; CD4+ helper T lymphocytes; Clinical outcome; Immune reconstitution

Indexed keywords

BUSULFAN; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUCONAZOLE; FLUDARABINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APHERESIS; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; DONOR; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; HUMAN; HUMAN CELL; LYMPH NODE IRRADIATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; MYELOABLATIVE CONDITIONING; NONHODGKIN LYMPHOMA; NONMYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SIBLING; T CELL DEPLETION; TOTAL PARENTERAL NUTRITION; UNIVARIATE ANALYSIS; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; BONE MARROW TRANSPLANTATION; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CHILD; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84860520305     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.0034-11     Document Type: Article

References (41)

1. Appelbaum FR. Haematopoietic cell transplantation as immunotherapy. Nature 2001; 411: 385-9. (Pubitemid 32467049)
2. Auletta JJ. Immune restoration following hematopoietic stem cell transplantation: an evolving target. Bone Marrow Transplant 2005; 35: 835-7.
3. Antin JH. Immune reconstitution: the major barrier to successful stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 43-5. (Pubitemid 40186225)
4. Storek J, Gooley T, Witherspoon RP et al. Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4T cell counts. Am J Hematol 1997; 54: 131-8. (Pubitemid 27079419)
5. Maraninchi D, Gluckman E, Blaise D, et al. Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukemias. Lancet 1987; 2: 175-8. (Pubitemid 17091848)
6. Reddy V, Iturraspe JA, Tzolas AC, et al. Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graftversus- host disease. Blood 2004; 103: 4330-3.
7. Shenoy S, Mohanakumar T, Todd G, et al. Immune reconstitution following allogeneic peripheral blood stem cell transplants. Bone Marrow Transplant 1999; 23: 335-46. (Pubitemid 29105957)
8. Savage1 WJ, Bleesing JJH, Douek D, et al. Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism. Bone Marrow Transplant 2001; 28: 463-71.
9. Clave E, Rocha V, Talvensaari K, et al. Prognostic value of pretrasplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation. Blood 2009; 105; 2608-13. (Pubitemid 40387066)
10. Dey BR, Shaffer J, Yee AJ, et al. Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen. Bone Marrow Transplant 2007; 40: 19-27. (Pubitemid 47018410)
11. Storek J, Dawson MA, Storer B, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001; 97; 3380-9.
12. Chen BJ, Cui X, Sempowski GD, et al. Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation. Blood 2004; 103; 4344-52. (Pubitemid 38685383)
13. Kim DH, Won D, Lee NY, et al. Non-CD34+ cells, especially CD8+ cytotoxic T cells and CD56+ natural killer cells, rather than CD34 cells, predict early engraftment and better transplantation outcomes in patients with hematologic malignancies after allogeneic peripheral stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 719-28. (Pubitemid 43899407)
14. Nguyen VH, Shashidhar S, Chang DS, et al. The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. Blood 2008; 111: 945-53.
15. Morecki S, Gelfand Y, Nagler A, et al. Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen. Bone Marrow Transplant 2001; 28: 243-9. (Pubitemid 32780876)
16. Larosa F, Marmier C, Robinet E, et al. Peripheral T-cell expansion and low infection rate after reduced-intensity conditioning and allogeneic blood stem cell transplantation. Bone Marrow Transplant 2005; 35: 859-68. (Pubitemid 40667628)
17. Abrahamsen IW, Somme S, Heldal D, et al. Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease. Haematologica 2005; 90: 86-93. (Pubitemid 40193758)
18. Hakki M, Riddel SR, Storek J, et al. Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy and subclinical reactivation. Blood 2003; 102: 3060-7. (Pubitemid 37248884)
19. Kim DH, Sohn SK, Won DI, et al. Rapid helper T-cell recovery above 200x106/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation. Bone Marrow Transplant 2006; 37: 1119-28. (Pubitemid 43871522)
20. Berger M, Figari O, Bruno B, et al. Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality. Bone Marrow Transplant 2008; 41: 55-62.
21. Lowsky R, Takahashi T, Liu YP, et al. Protective conditioning for acute graft-versus-host disease. N Engl J Med 2005; 353: 1321-1331. (Pubitemid 41362700)
22. Przepiorka D, Weisdorf D, Martin P, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-8.
23. Ratanatharathorn V, Ayash L, Lazarus HM, et al. Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplant 2001; 28: 121-9. (Pubitemid 32725712)
24. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-17. (Pubitemid 10036817)
25. Novitzky N, Davison GM, Hale G, Waldmann H. Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome. Transplantation 2002; 74: 1551-9. (Pubitemid 36014228)
26. Koehl U, Bochennek K, Zimmermann SY, et al. Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+CD3+ count reconstitution is associated with survival. Bone Marrow Transplant 2007; 39: 269-78. (Pubitemid 46322633)
27. Powles R, Singhal S, Treleaven J, et al. Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute leukaemia on the basis of lymphocyte recovery early after transplantation. Blood 1998; 11: 3481-6.
28. Flavell RA. The molecular basis of T cell differentiation. Immunol Res 1999; 19: 159-68. (Pubitemid 29401373)
29. Husmann LA, Bevan MJ. Cooperation between helper T cells and cytotoxic T lymphocyte precursors. Ann NY Acad Sci 1988; 532: 158-69. (Pubitemid 19017636)
30. Kalams SA, Walker BD. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med 1998; 188: 2199-204. (Pubitemid 29028492)
31. Ottinger HD, Beelen DW, Scheulen B, et al. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996; 88: 2775-9. (Pubitemid 26327533)
32. Koh LP, Rizzieri DA, Chao NJ. Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors. Biol Blood Marrow Transplant 2007; 13: 1249-67. (Pubitemid 47571038)
33. Eyrich M, Leiler C, Lang P, et al. A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors. Bone Marrow Transplant 2003; 32: 379-90. (Pubitemid 37038847)
34. Kumar P, Defor TE, Brunstein C, et al. Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival. Biol Blood Marrow Transplant 2008; 14: 1394-400.
35. Crocchiolo R, Ciceri F, Fleischhauer K, et al. HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry. Bone Marrow Transplant 2009; 44: 571-7.
36. Gratwohl A, Brand R, Apperley J, et al. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood 2002; 100: 3877-86. (Pubitemid 35396852)
37. Guardiola P, Socié G, Li X, et al. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome. Blood 2004; 103: 73-7. (Pubitemid 38029920)
38. Kim DH, Sohn SK, Kim JG, et al. Clinical impact of hyperacute graft-versus-host disease on results of allogeneic stem cell transplantation. Bone Marrow Transplant 2004; 33: 1025-30. (Pubitemid 38744789)
39. Helming AM, Brand A, Wolterbeek R, et al. ABO incompatible stem cell transplantation in children does not influence outcome. Pediatr Blood Cancer 2007; 49: 313-7. (Pubitemid 47236222)
40. Worel N, Kalhs P, Keil F, et al. ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation. Transfusion 2003; 43: 1153-61. (Pubitemid 37022378)
41. Stussi G, Seebach L, Muntwyler J, et al. Graft-versus-host disease and survival after ABO-incompatible allogeneic bone marrow transplantation: a single-centre experience. Br J Haematol 2001; 113: 251-3. (Pubitemid 32423331)